Incyte Corporation Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 ACAD
|
ACADIA Pharmaceuticals Inc. | $16.20 | $2.46 B | -40.24 | 620 | $726.44 M |
 ALNY
|
Alnylam Pharmaceuticals, Inc. | $246.98 | $19.33 B | -57.65 | 2100 | $1.83 B |
 APLS
|
Apellis Pharmaceuticals, Inc. | $27.74 | $4.90 B | -11.77 | 702 | $396.59 M |
 ARGX
|
argenx SE | $596.56 | $22.33 B | -66.05 | 1148 | $1.23 B |
 ARWR
|
Arrowhead Pharmaceuticals, Inc. | $18.27 | $2.97 B | -5.65 | 525 | $240.74 M |
 AXSM
|
Axsome Therapeutics, Inc. | $98.13 | $3.51 B | -11.46 | 607 | $270.60 M |
 BGNE
|
BeiGene, Ltd. | $194.39 | $17.07 B | -20.76 | 10600 | $2.46 B |
 BMRN
|
BioMarin Pharmaceutical Inc. | $63.45 | $15.32 B | 76.12 | 3401 | $2.42 B |
 DNLI
|
Denali Therapeutics Inc. | $24.23 | $2.96 B | -22.1 | 390 | $330.53 M |
 FOLD
|
Amicus Therapeutics, Inc. | $9.49 | $2.98 B | -20.51 | 500 | $399.36 M |
 HRMY
|
Harmony Biosciences Holdings, Inc. | $33.25 | $1.73 B | 13.15 | 246 | $582.02 M |
 IMGN
|
ImmunoGen, Inc. | $31.24 | $8.73 B | -111.55 | 277 | $108.78 M |
 IONS
|
Ionis Pharmaceuticals, Inc. | $33.96 | $5.69 B | -14.59 | 927 | $787.65 M |
 RARE
|
Ultragenyx Pharmaceutical Inc. | $45.98 | $3.44 B | -5.21 | 1276 | $434.25 M |
 RXDX
|
Prometheus Biosciences, Inc. | $199.92 | $9.56 B | -56.47 | 97 | $6.81 M |
 SRPT
|
Sarepta Therapeutics, Inc. | $110.55 | $11.66 B | 286.79 | 1314 | $1.24 B |
 UTHR
|
United Therapeutics Corporation | $367.42 | $12.20 B | 13.02 | 1168 | $2.33 B |